Scientists at ETH Zurich have made significant progress in developing a ready-to-use immunotherapy treatment for cancer. A synthetic protein modification can allow immune cells from any donor to be delivered to any patient without the risk of an adverse immunological … [Read more...] about Universal cancer immunotherapy may be possible through protein engineering
Immunotherapy
Novel blood cancer treatment effective in three-fourths of trial patients
According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent of patients with multiple myeloma, a lethal form of blood cancer. Based on these encouraging findings, an … [Read more...] about Novel blood cancer treatment effective in three-fourths of trial patients
New treatment makes cancer cells obvious targets for immune system
Cancer is a condition that involves the development of abnormal cells in a certain part of the body that divide uncontrollably, so much so that it can spread to other parts of the body. It is one of the leading causes of death worldwide. Researchers, medical professionals, and … [Read more...] about New treatment makes cancer cells obvious targets for immune system
New immunotherapy drug combo slows liver cancer growth in mice
There is something of an art to the science of medicine. We’ve all heard that everyone’s different, and so is their biology. Sometimes, developing the right treatment for a patient’s condition takes dedicated and creative trial and error with their doctor, and finding the right … [Read more...] about New immunotherapy drug combo slows liver cancer growth in mice
Researchers pinpoint the driver of metastasis
Metastasis is the process of cancer spreading through the body. It happens when cells break away from a tumor, traveling around the body to implant themselves in other areas. Unfortunately, this phenomenon renders chemotherapy and immunotherapy pretty ineffective. For decades, … [Read more...] about Researchers pinpoint the driver of metastasis